Search results for "Coronavirus"
ACP, Annals of Internal Medicine host ninth forum on COVID-19
A full recording of COVID-19 Forum IX: Management of Patients with Persistent Symptoms after COVID-19 is available for replay online.
https://acpinternist.org/weekly/archives/2022/05/31/4.htm
31 May 2022
Stronger warning for montelukast; COVID-19 actions
This column reviews details on recent recalls, warnings, and approvals.
https://acpinternist.org/archives/2020/05/stronger-warning-for-montelukast-covid-19-actions.htm
1 May 2020
COVID-19 and primary care
This issue also covers personal protective equipment and retirement planning.
https://acpinternist.org/archives/2020/07/covid-19-and-primary-care.htm
1 Jul 2020
The pain of 2020 and the hope for 2021
We have lost so much this past year, but loss also reminds us of our abundant blessings, so many we take for granted daily.
https://acpinternist.org/archives/2020/11/the-pain-of-2020-and-the-hope-for-2021.htm
1 Nov 2020
Home BP monitoring works, but not as well alone
Home blood pressure monitoring needs to be combined with other interventions and the data collected must be used to engage the patient in some way to have the greatest effect.
https://acpinternist.org/archives/2020/11/home-bp-monitoring-works-but-not-as-well-alone.htm
1 Nov 2020
Infusion sets, heparin recalled
This column reviews details on recent recalls, warnings, and approvals.
https://acpinternist.org/archives/2020/10/infusion-sets-heparin-recalled.htm
1 Oct 2020
Following up on breast density
This issue also covers vaccination practices and resources for managing the COVID-19 pandemic.
https://acpinternist.org/archives/2020/06/following-up-on-breast-density.htm
1 Jun 2020
Studies examine persistent symptoms of COVID-19
A U.K. study found that COVID-19 vaccination after infection may help persistent symptoms, while a U.S. study found that the burden of such symptoms appears high.
https://acpinternist.org/weekly/archives/2022/05/24/5.htm
24 May 2022
IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir
The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital profits during the pandemic.
https://acpinternist.org/weekly/archives/2022/05/17/2.htm
17 May 2022
Fourth vaccine dose 62% effective against severe COVID-19 in month after receipt
Retrospective data from Israel showed that in people ages 60 years and older, an additional booster dose of the Pfizer-BioNTech COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization.
https://acpinternist.org/weekly/archives/2022/04/19/4.htm
19 Apr 2022